Literature DB >> 17901084

Home-based versus clinic-based self-sampling and testing for sexually transmitted infections in Gugulethu, South Africa: randomised controlled trial.

H E Jones1, L Altini, A de Kock, T Young, J H H M van de Wijgert.   

Abstract

OBJECTIVES: To test whether more women are screened for sexually transmitted infections when offered home-based versus clinic-based testing and to evaluate the feasibility and acceptability of self-sampling and self-testing in home and clinic settings in a resource-poor community.
METHODS: Women aged 14-25 were randomised to receive a home kit with a pre-paid addressed envelope for mailing specimens or a clinic appointment, in Gugulethu, South Africa. Self-collected vaginal swabs were tested for gonorrhoea, chlamydia and trichomoniasis using PCR and self-tested for trichomoniasis using a rapid dipstick test. All women were interviewed at enrollment on sociodemographic and sexual history, and at the 6-week follow-up on feasibility and acceptability.
RESULTS: 626 women were enrolled in the study, with 313 in each group; 569 (91%) completed their 6-week follow-up visit. Forty-seven per cent of the women in the home group successfully mailed their packages, and 13% reported performing the rapid test and/or mailing the kit (partial responders), versus 42% of women in the clinic group who kept their appointment. Excluding partial responders, women in the home group were 1.3 (95% CI 1.1 to 1.5) times as likely to respond to the initiative as women in the clinic group. Among the 44% who were tested, 22% tested positive for chlamydia, 10% for trichomoniasis, and 8% for gonorrhoea.
CONCLUSIONS: Self-sampling and self-testing are feasible and acceptable options in low-income communities such as Gugulethu. As rapid diagnostic tests become available and laboratory infrastructure improves, these methodologies should be integrated into services, especially services aimed at young women.

Entities:  

Mesh:

Year:  2007        PMID: 17901084      PMCID: PMC2598654          DOI: 10.1136/sti.2007.027060

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  11 in total

Review 1.  Approaches to the control of sexually transmitted infections in developing countries: old problems and modern challenges.

Authors:  P Mayaud; D Mabey
Journal:  Sex Transm Infect       Date:  2004-06       Impact factor: 3.519

2.  Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples.

Authors:  G Madico; T C Quinn; A Rompalo; K T McKee; C A Gaydos
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

Review 3.  Global control of sexually transmitted infections.

Authors:  Nicola Low; Nathalie Broutet; Yaw Adu-Sarkodie; Pelham Barton; Mazeda Hossain; Sarah Hawkes
Journal:  Lancet       Date:  2006-12-02       Impact factor: 79.321

4.  Evaluation of self-collected samples in contrast to practitioner-collected samples for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis by polymerase chain reaction among women living in remote areas.

Authors:  Janet Knox; Sepehr N Tabrizi; Penny Miller; Kathy Petoumenos; Mathew Law; Shujun Chen; Suzanne M Garland
Journal:  Sex Transm Dis       Date:  2002-11       Impact factor: 2.830

5.  Home screening for sexually transmitted diseases in high-risk young women: randomised controlled trial.

Authors:  Robert L Cook; Lars Østergaard; Sharon L Hillier; Pamela J Murray; Chung-Chou H Chang; Diane M Comer; Roberta B Ness
Journal:  Sex Transm Infect       Date:  2007-02-14       Impact factor: 3.519

6.  Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections.

Authors:  Julius Schachter; Max A Chernesky; Dean E Willis; Paul M Fine; David H Martin; Deanna Fuller; Jeanne A Jordan; William Janda; Edward W Hook
Journal:  Sex Transm Dis       Date:  2005-12       Impact factor: 2.830

7.  Home-based self-sampling and self-testing for sexually transmitted infections: acceptable and feasible alternatives to provider-based screening in low-income women in São Paulo, Brazil.

Authors:  Sheri A Lippman; Heidi E Jones; Carla G Luppi; Adriana A Pinho; Maria Amelia M S Veras; Janneke H H M van de Wijgert
Journal:  Sex Transm Dis       Date:  2007-07       Impact factor: 2.830

Review 8.  Sentinel surveillance of sexually transmitted infections in South Africa: a review.

Authors:  L F Johnson; D J Coetzee; R E Dorrington
Journal:  Sex Transm Infect       Date:  2005-08       Impact factor: 3.519

9.  A comparison of two methods of partner notification for sexually transmitted infections in South Africa: patient-delivered partner medication and patient-based partner referral.

Authors:  T Young; A de Kock; H Jones; L Altini; T Ferguson; J van de Wijgert
Journal:  Int J STD AIDS       Date:  2007-05       Impact factor: 1.359

10.  Comparing first-void urine specimens, self-collected vaginal swabs, and endocervical specimens to detect Chlamydia trachomatis and Neisseria gonorrhoeae by a nucleic acid amplification test.

Authors:  Mary-Ann Shafer; Jeanne Moncada; Cherrie B Boyer; Kelli Betsinger; Scott D Flinn; Julius Schachter
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

View more
  21 in total

1.  Travelling far but staying close to home.

Authors:  Nicola Low; Sevgi Aral; Jackie A Cassell
Journal:  Sex Transm Infect       Date:  2007-12       Impact factor: 3.519

2.  Cervicovaginal self-sampling is a reliable method for determination of prevalence of human papillomavirus genotypes in women aged 20 to 30 years.

Authors:  Yvonne Deleré; Melanie Schuster; Elena Vartazarowa; Thomas Hänsel; Ingke Hagemann; Simone Borchardt; Heike Perlitz; Achim Schneider; Sabine Reiter; Andreas M Kaufmann
Journal:  J Clin Microbiol       Date:  2011-08-03       Impact factor: 5.948

3.  Performance of a rapid self-test for detection of Trichomonas vaginalis in South Africa and Brazil.

Authors:  Heidi E Jones; Sheri A Lippman; Helio H Caiaffa-Filho; Taryn Young; Janneke H H M van de Wijgert
Journal:  J Clin Microbiol       Date:  2013-01-16       Impact factor: 5.948

Review 4.  A review of current practices to increase Chlamydia screening in the community--a consumer-centred social marketing perspective.

Authors:  Lyn Phillipson; Ross Gordon; Joanne Telenta; Chris Magee; Marty Janssen
Journal:  Health Expect       Date:  2015-01-12       Impact factor: 3.377

Review 5.  Home versus clinic-based specimen collection for Chlamydia trachomatis and Neisseria gonorrhoeae.

Authors:  Anna S Graseck; Shirley L Shih; Jeffrey F Peipert
Journal:  Expert Rev Anti Infect Ther       Date:  2011-02       Impact factor: 5.091

Review 6.  Screening for sexually transmitted infections at home or in the clinic?

Authors:  Shirley L Shih; Anna S Graseck; Gina M Secura; Jeffrey F Peipert
Journal:  Curr Opin Infect Dis       Date:  2011-02       Impact factor: 4.915

7.  Acceptability of self-testing for trichomoniasis increases with experience.

Authors:  Jill S Huppert; Elizabeth A Hesse; Molly A Bernard; Yang Xiao; Bin Huang; Charlotte A Gaydos; Jessica A Kahn
Journal:  Sex Transm Infect       Date:  2011-07-27       Impact factor: 3.519

8.  Feasibility, Acceptability, and Accuracy of Vaginal Self-Sampling for Screening Human Papillomavirus Types in Women from Rural Areas in Senegal.

Authors:  Ndeye Safietou Fall; Catherine Tamalet; Nafissatou Diagne; Florence Fenollar; Didier Raoult; Cheikh Sokhna; Jean-Christophe Lagier
Journal:  Am J Trop Med Hyg       Date:  2019-06       Impact factor: 2.345

Review 9.  Home testing past, present and future: lessons learned and implications for HIV home tests.

Authors:  Mobolaji Ibitoye; Timothy Frasca; Rebecca Giguere; Alex Carballo-Diéguez
Journal:  AIDS Behav       Date:  2014-05

Review 10.  Screening for genital chlamydia infection.

Authors:  Nicola Low; Shelagh Redmond; Anneli Uusküla; Jan van Bergen; Helen Ward; Berit Andersen; Hannelore Götz
Journal:  Cochrane Database Syst Rev       Date:  2016-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.